| |
Underweight BMI
|
Normal BMI
|
Overweight BMI
|
Obese BMI
|
|---|
|
Baseline
|
|
Average duration of attack (h)
|
|
n
|
12
|
150
|
106
|
41
|
|
Mean ± SDa
|
50.7 ± 22.9
|
40.5 ± 32.4
|
45.9 ± 31.5
|
44.4 ± 35.5
|
|
Median (range)
|
48.0 (6–92)
|
41.0 (0–140)
|
48.0 (0–156)
|
48.0 (0–120)
|
|
Follow-up
|
|
Average duration of attack (h)
|
|
n
|
11
|
76
|
70
|
25
|
|
Mean ± SDa
|
34.6 ± 21.6
|
39.7 ± 31.1
|
37.6 ± 30.6
|
44.2 ± 29.9
|
|
Median (range)
|
36 (0–72)
|
37.5 (0–144)
|
28.7 (0–120)
|
48.0 (0.3–120)
|
- Average duration of untreated attacks corresponds to mean of average durations of untreated attacks at the skin, abdomen, larynx, and other sites
- BMI body mass index; SD standard deviation; n = the number of patients
- aP values comparing average duration of attack at baseline between patients with normal/overweight/obese BMI: P = 0.408 at baseline; P = 0.530 at follow-up. Results excluding data from the two reinjection outliers are presented in Additional file 1: Table S2
